Skip to main content
×
Home
    • Aa
    • Aa

Changes in measles seroepidemiology of healthcare workers in southern Taiwan

  • T. S. HO (a1), S. M. WANG (a1), L. R. WANG (a2) and C. C. LIU (a2) (a3)
Summary
SUMMARY

To assess the measles seroepidemiology of healthcare workers (HCWs), from 2004 to 2009 all newly recruited staff at a university hospital in Taiwan, were tested for specific immunoglobulin G antibodies for measles virus using enzyme-linked immunosorbent assays. A total of 1584 HCWs were included. The positivity rate of measles antibody for physicians and nurses was about 90%. The positivity of measles antibody in different age groups was 78·1%, 93·9% and 94·2% for 20–29, 30–39 and ⩾40 years age groups, respectively. Equivocal results were more frequent in the 20–29 (17·1%) years age group. A lack of antibody against measles was reported for 66 (4·2%) of those tested. Medical student (8·3%) and housekeeping personnel (5·3%) had the greatest lack of antibodies. This study demonstrates the waning measles immunity in younger HCWs in Taiwan, which poses the potential risk of nosocomial transmission of measles. Periodic surveillance and revaccination of susceptible HCWs is recommended.

Copyright
Corresponding author
*Author for correspondence: Dr C. C. Liu, Department of Paediatrics, National Cheng Kung University Medical College and Hospital, No.138, Sheng-Li Road, Tainan 704, Taiwan. (Email: liucc@mail.ncku.edu.tw) [C. C. Liu]
(Email: pedwang@mail.ncku.edu.tw) [S. M. Wang]
References
Hide All
1.World Health Organization. Measles. WHO Fact Sheet No. 268 (http://www.who.int/mediacentre/factsheets/fs286/en/index.html). Accessed 20 October 2010.
2.Godoy P, et al. Measles epidemiology in Catalonia (Spain): implications for a regional vaccination programme. International Journal of Epidemiology 1999; 28: 558562.
3.Moss WJ. Measles control and the prospect of eradication. Current Topics in Microbiology and Immunology 2009; 330: 173189.
4.Centers for Disease Control and Prevention.Progress in global measles control and mortality reduction, 2000–2007. Morbidity and Mortality Weekly Report 2008; 57: 13031306.
5.Lee MS, et al. Epidemiology of measles in Taiwan: dynamics of transmission and timeliness of reporting during an epidemic in 1988–9. Epidemiology and Infection 1995; 114: 345359.
6.Lee MS, et al. Seroepidemiology and evaluation of passive surveillance during 1988–1989 measles outbreak in Taiwan. International Journal of Epidemiology 1992; 21: 11651174.
7.Liu CC, Lei HY, Chiang YP. Seroepidemiology of measles in southern Taiwan: two years after implementation of the measles elimination program. Journal of Formosan Medical Association 1996; 95: 3740.
8.Cheng WY, et al. Molecular evolution of measles viruses circulated in Taiwan 1992–2008. Virology Journal 2009; 6: 219.
9.Lin HJ, et al. Measles cluster in Tainan area, early 2009. Taiwan Epidemiology Bulletin 2010; 26: 1225.
10.Lee NY, et al. Modified measles in a healthcare worker after return from travel. Infection Control and Hospital Epidemiology 2008; 29: 380381.
11.Nagano H, et al. Epidemiological and molecular studies of measles at different clusters in hokkaido district, Japan, 2007. Japanese Journal of Infectious Diseases 2009; 62: 209211.
12.Mendelson GM, et al. Nosocomial transmission of measles to healthcare workers. Time for a national screening and immunization policy for NHS staff? Journal of Hospital Infection 2000; 44: 154155.
13.Biellik RJ, Clemens CJ. Strategies for minimizing nosocomial measles. Transmission. Bulletin of the World Health Organization 1997; 75: 367375.
14.Atkinson WL, et al. Transmission of measles in medical settings – United States, 1985–1989. American Journal of Medicine 1991; 91: 320S324S.
15.Davis RM, et al. Transmission of measles in medical settings: 1980 through 1984. Journal of American Medical Association 1986; 255: 12951298.
16.Lee SS, et al. Nosocomial transmission of undetected, imported measles in Taiwan, 2008. Infection Control and Hospital Epidemiology 2009; 30: 10261028.
17.Weigle KA, Murphy MD, Brunell PA. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. Journal of Clinical Microbiology 1984; 19: 376379.
18.Chen SC, et al. Modelling vaccination programmes against measles in Taiwan. Epidemiology and Infection 2007; 135: 775786.
19.Watson JC, et al. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 1998; 47: 157.
20.Lee MS, et al. Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995–1997. Vaccine 2001; 19: 46444651.
21.McDonald LC, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerging Infectious Diseases 2004; 10: 777781.
22.Yalcin SS, Kanra G, Pehlivan T. Outbreak of measles in medical students and determination of immune status to measles-mumps-rubella viruses. International Journal of Adolescent Medicine and Health 2006; 18: 615622.
23.Wicker S, et al. Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Medical Microbiology and Immunology 2007; 196: 145150.
24.Williams CJ, et al. Low measles, mumps and rubella (MMR) vaccine uptake in hospital healthcare worker contacts following suspected mumps infection. Journal of Hospital Infection 2010; 76: 9192.
25.Tischer A, Gerike E. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Vaccine 2000; 18: 13821392.
26.Wang ET, et al. Emergency response and policy consideration on measles epidemics. Taiwan Epidemiology Bulletin 2007; 23: 308–26.
27.Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. New England Journal of Medicine 2007; 357: 19031915.
28.Dine MS, et al. Persistence of vaccine-induced antibody to measles 26–33 years after vaccination. Journal of Infectious Diseases 2004; 189: S123S130.
29.Davidkin I, et al. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. Journal of Infectious Diseases 2008; 197: 950956.
30.Hatakeyama S, et al. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan. Infection Control and Hospital Epidemiology 2004; 25: 591594.
31.Fedeli U, Zanetti C, Saia B. Susceptibility of healthcare workers to measles, mumps, rubella and varicella. Journal of Hospital Infection 2002; 51: 133135.
32.Almuneef MA, et al. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infection Control and Hospital Epidemiology 2006; 27: 11781183.
33.Williamson D, et al. Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: additional justification for assumption of age-determined immunity based on local data. Infection Control and Hospital Epidemiology 2010; 31: 10821084.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 1
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 87 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th October 2017. This data will be updated every 24 hours.